NXbio Development AB

ABActive

Org 5565121794Storjordenvägen 2, 864 31 MatforsManufacture of pharmaceutical preparations· NACE 2120Est. 1995 · 31 years old2 employees

Overview Financials People & ownership Related companies

NXbio Development AB is a Swedish AB based in Matfors, operating in the Manufacture of pharmaceutical preparations sector. Incorporated in 1995, the company has 2 employees and reported revenue of SEK 0 in its latest annual filing.

Revenue 2024

SEK 0

EBITDA margin

—

Net profit 2024

SEK -11M

+76% vs 2023

Key ratios

See full ratios →

36.7%

This company

20202024

2178.4×

This company

20202024

-5.7%

This company

20202024

EBITDA — year on year

SEK millions

Key figures

Annual report 2024

Revenue	SEK 0	—
EBITDA	SEK -79K	+44%
Net profit	SEK -11M	+76%
Total assets	SEK 191,8M	+49%
Equity	SEK 70,4M	-13%
Employees	2	—

Contact

Address

Storjordenvägen 2, 864 31 Matfors

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of NXbio Development AB?

NXbio Development AB is registered with Bolagsverket / SCB under Org 5565121794.

How many employees does NXbio Development AB have?

NXbio Development AB employs 2 people as of the latest annual report.

Who is the chairman of NXbio Development AB?

Maria Ingrid Rynell chairs the board of NXbio Development AB, in role since 2022.

Where is NXbio Development AB headquartered?

NXbio Development AB's registered address is Storjordenvägen 2.

NXbio Development AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on NXbio Development AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on NXbio Development AB